Skip to main content
Log in

Implications of surgical intervention in the treatment of neuroblastomas: 20-year experience of a single institution

Surgery Today Aims and scope Submit manuscript

Abstract

Purpose

The implications of surgical intervention for neuroblastomas were assessed in one institution.

Methods

We analyzed the clinical characteristics and extension of resection in 123 pediatric patients with neuroblastoma diagnosed between 1985 and 2004.

Results

The 5-year survival rate of the 82 patients under 12 months of age, 59 of whom were treated with complete resection of the primary tumor, was 97%. The 5-year survival rate of the 41 patients over 12 months of age did not differ significantly according to whether complete (n = 19) or incomplete resection (n = 22) was performed (46 vs. 38%, respectively). No local recurrence was observed in ten patients over 12 months of age with stage 4 disease who underwent complete resection of the primary tumor; however, four of these ten patients died of metastatic recurrence.

Conclusion

Considering that the majority of infantile neuroblastomas in this study had favorable biology, complete resection might be unnecessary for patients under 12 years of age. For advanced neuroblastomas in patients over 12 months of age, the main treatment for metastasis is systemic chemotherapy, although extirpation of the primary tumor without extensive surgery might prevent local recurrence when combined with radiation therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

References

  1. Crist WM, Kun LE. Common solid tumors of childhood. N Engl J Med. 1991;324:461–71.

    Article  PubMed  CAS  Google Scholar 

  2. Bodeur GM. Molecular basis for heterogeneity in human neuroblastoma. Eur J Cancer. 1995;31:505–10.

    Article  Google Scholar 

  3. Tajiri T, Shono K, Tanaka S, Suita S. Evaluation of genetic heterogeneity in neuroblastoma. Surgery (St. Louis). 2002;131:283–7.

    Article  Google Scholar 

  4. Kubota M. The role of surgery in the treatment of neuroblastoma. Surg Today. 2010;40:526–32.

    Article  PubMed  Google Scholar 

  5. Tanaka S, Tajiri T, Noguchi S, Ihara K, Hara T, Suita S. Clinical significance of a highly sensitive analysis for gene dosage and the expression level of MYCN in neuroblastoma. J Pediatr Surg. 2004;39:63–8.

    Article  PubMed  Google Scholar 

  6. Brodeur GM, Pritchard J, Berthold F. Revision of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol. 1993;11:1466–77.

    PubMed  CAS  Google Scholar 

  7. Matsumura T, Sawada T, Shikata T. New trend in treatment strategy for neuroblastoma infants in Japan. Proceedings of the 32nd Annual Meeting of American Society of Clinical Oncology. J Clin Oncol. 1996;15:461.

    Google Scholar 

  8. Iehara T, Hosoi H, Akazawa K, Matsumoto Y, Suita S, et al. MYCN gene amplification is a powerful prognostic factor even in infantile neuroblastoma detected by mass screening. Br J Cancer. 2006;94:1510–5.

    Article  PubMed  CAS  Google Scholar 

  9. Kaneko M, Tsuchida Y, Uchino J, Takeda T, Iwafuchi M, Ohnuma N, et al. Treatment results of advanced neuroblastoma with the First Japanese Study Group Protocol. J Pediatr Hematol Oncol. 1999;21:190–7.

    Article  PubMed  CAS  Google Scholar 

  10. Kaneko M, Tsuchida Y, Mugishima H, Ohnuma N, Yamamoto K, Kawa K, et al. Intensified chemotherapy increases the survival rates in state 4 neuroblastoma with MYCN amplification. J Pediatr Hematol Oncol. 2002;24:613–21.

    Article  PubMed  Google Scholar 

  11. Brodeur GM, Maris JM, Yamashiro DJ. Biology and genetics of human neuroblastomas. J Pediatr Hematol Oncol. 1997;19:93–101.

    Article  PubMed  CAS  Google Scholar 

  12. Suita S, Tajiri T, Kaneko M, Hirai M, Mugishima H, Sugimoto T, Tsuchida Y. Implications of MYCN amplification in patients with stage 4 neuroblastoma who undergo intensive chemotherapy. J Pediatr Surg. 2007;42:489–93.

    Article  PubMed  Google Scholar 

  13. Suita S, Tajiri T, Higashi M, Tanaka S, Kinoshita Y, Takahashi Y, et al. Insights into infant neuroblastomas based on an analysis of neuroblastomas detected by mass screening at 6 months of age in Japan. Eur J Pediatr Surg. 2007;17:23–8.

    Article  PubMed  CAS  Google Scholar 

  14. Yamamoto K, Hanada R, Tanimura M, Aihara T, Hayashi Y. Natural history of neuroblastoma found by mass screening. Lancet. 1997;349:1102.

    Article  PubMed  CAS  Google Scholar 

  15. Cecchetto G, Mosseri V, De Bernardi B. Surgical risk factors in primary surgery for localized neuroblastoma: the LNESG1 study of the European International Society of Pediatric Oncology Neuroblastoma Group. J Clin Oncol. 2005;23:8483–9.

    Article  PubMed  Google Scholar 

  16. Simon T, Hero B, Bohm GB, Schweinitz D, Berthold F. Review of image defined risk factors in localized neuroblastoma patients: results of the GPOH NB97 trial. Pediatr Blood Cancer. 2008;50:965–9.

    Article  PubMed  Google Scholar 

  17. La Quaglia MP, Kushner BH, Heller G. Stage 4 neuroblastoma diagnosed at more than 1 year of age: gross total resection and clinical outcome. J Pediatr Surg. 1994;29:1162–6.

    Article  PubMed  CAS  Google Scholar 

  18. Adkins ES, Sawin R, Gerbing RB, London WB, Matthay KK, Haase GM. Efficacy of complete resection for high risk neuroblastoma: a Children’s Cancer Group study. J Pediatr Surg. 2004;39:931–6.

    Article  PubMed  Google Scholar 

  19. Kuroda T, Saeki M, Honna T. Clinical significance of intensive surgery with intraoperative radiation for advanced neuroblastoma: does it really make sense? J Pediatr Surg. 2003;38:1735–8.

    Article  PubMed  Google Scholar 

  20. Castel V, Tovar JA, Costa E. The role of surgery in stage IV neuroblastoma. J Pediatr Surg. 2002;37:1574–8.

    Article  PubMed  Google Scholar 

  21. Kaneko M, Ohkawa H, Iwakawa M. Is extensive surgery required for treatment of advanced neuroblastoma? J Pediatr Surg. 1997;32:1616–9.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This work was supported in part by a grant-in-aid for scientific research from the Japanese Society for the Promotion of Science.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tatsuro Tajiri.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tajiri, T., Souzaki, R., Kinoshita, Y. et al. Implications of surgical intervention in the treatment of neuroblastomas: 20-year experience of a single institution. Surg Today 42, 220–224 (2012). https://doi.org/10.1007/s00595-011-0053-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00595-011-0053-0

Keywords

Navigation